
STERIS (STE) Stock Forecast & Price Target
STERIS (STE) Analyst Ratings
Bulls say
Steris reported total revenue of $1,480.5 million for fiscal fourth quarter 2025, reflecting a 5.0% year-over-year increase on an organic basis. The company's EBIT margin improved by 110 basis points compared to the previous year, indicating enhanced operational efficiency. Additionally, Steris achieved a quarterly earnings per share (EPS) of $2.74, representing a 14% increase from the prior-year period, supported by lower interest expenses following the divestment of its dental segment.
Bears say
Steris has reported a significant decline in its capital equipment segment, with a decrease of approximately 16% year-over-year, while service revenues fell by 21%, indicating a weak demand in critical areas of its business. The company’s capital backlog has also shown a concerning trend, dropping by $1 million to $84 million compared to the prior period, raising questions about its future sales potential. Furthermore, achieving sustained earnings and dividend growth appears challenging, as the company relies on mid-single digit revenue growth, which may be difficult given the current market dynamics and potential delays in capital equipment sales recovery.
This aggregate rating is based on analysts' research of STERIS and is not a guaranteed prediction by Public.com or investment advice.
STERIS (STE) Analyst Forecast & Price Prediction
Start investing in STERIS (STE)
Order type
Buy in
Order amount
Est. shares
0 shares